CNS Pharmaceuticals

Yahoo Finance • 5 months ago

CNS Pharmaceuticals reports Q3 results

* CNS Pharmaceuticals press release [https://seekingalpha.com/pr/20309728-cns-pharmaceuticals-reports-third-quarter-2025-financial-results-and-provides-corporate] (CNSP [https://seekingalpha.com/symbol/CNSP]): Q3 The net loss for the thr... Full story

Yahoo Finance • 8 months ago

CNS Pharmaceuticals upgraded to Buy at Maxim on TPI-287 roadmap

As previously reported, Maxim upgraded CNS Pharmaceuticals (CNSP) to Buy from Hold with a $20 price target The company has pivoted to its oncology asset TPI-287, a blood brain barrier crossing taxane in development initially for recurrent... Full story

Yahoo Finance • 9 months ago

CNS Pharmaceuticals Announces Reverse Stock Split

HOUSTON, TX / ACCESS Newswire / July 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the bra... Full story

Yahoo Finance • 3 years ago

JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th

- Live video webcast presentations with participating companies - FRENCHTOWN, NJ / ACCESSWIRE / January 11, 2023 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the... Full story